Vivimed Labs Ltd Locks at Lower Circuit With 4.97% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the EQ series, hit its lower circuit at Rs 5.55, down Rs 0.29 from the previous close, within a 5% price band. This band capped the maximum daily loss allowed, and the circuit breaker effectively froze trading at this floor price. The total traded volume was 72,281 shares, with a turnover of just ₹0.04 crore, reflecting the limited liquidity on the day. The unfilled supply scenario is clear: sellers were lined up to exit, but buyers were absent, creating a queue of unexecuted sell orders. This dynamic is typical for micro-cap stocks like Vivimed Labs Ltd, where liquidity constraints exacerbate exit difficulties. Vivimed Labs Ltd’s market capitalisation stands at a modest ₹47 crore, underscoring its micro-cap status and the attendant liquidity risks. With unfilled sell orders at Rs 5.55 and near-zero liquidity, how deep is the exit problem for Vivimed Labs Ltd and what would need to change for normal trading to resume?

Delivery and Volume Analysis

Delivery volumes on 25 Mar rose sharply to 2.47 lakh shares, a 66.89% increase over the 5-day average delivery volume. On a lower circuit day, this surge in delivery volume is significant: it indicates genuine selling by holders liquidating actual positions rather than speculative short-selling. This contrasts with rising delivery on upper circuit days, which signals buying conviction. The total traded volume on the circuit day was lower than usual, a mechanical effect of the price freeze, but the elevated delivery volume from two days prior suggests that selling pressure has been building steadily. This pattern points to a capitulation phase, where holders are offloading shares amid falling prices rather than intraday traders opening shorts. Delivery volumes surged 66.89% on a lower circuit day — when holders are liquidating at these levels, is this capitulation or just the beginning for Vivimed Labs Ltd?

Intraday Price Action

The intraday range for Vivimed Labs Ltd was relatively narrow, with a high of Rs 5.89 and a low of Rs 5.55, the lower circuit price. The stock opened near the upper end of this range but steadily declined throughout the session, closing at the circuit floor. This steady descent without any significant rebound highlights persistent selling pressure and the absence of buyers willing to step in even as prices fell. The 4.97% loss represents the maximum permitted decline under the 5% price band, and the circuit lock prevented further price discovery. Did the stock’s intraday decline signal a capitulation phase or is this a continuation of a longer downtrend?

Moving Averages and Trend Context

Vivimed Labs Ltd is trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning confirms a sustained downtrend that preceded the lower circuit event. The stock has been falling for six consecutive sessions, losing 14.88% over this period, which indicates persistent weakness. The alignment below all moving averages suggests that any short-term rallies may face resistance, and the current circuit lock may be an acceleration of an already negative trend. Below all moving averages and now locked at lower circuit — does the technical profile of Vivimed Labs Ltd show any support level nearby, or is the next floor lower still?

Liquidity and Exit Risk

As a micro-cap stock with a market capitalisation of ₹47 crore, Vivimed Labs Ltd faces significant liquidity constraints. The total turnover of ₹0.04 crore on the circuit day is modest, and the stock’s liquidity allows for a trade size of effectively zero based on 2% of the 5-day average traded value. This means that any sizeable position faces severe exit friction, as the market depth is insufficient to absorb large sell orders without triggering further price declines. The circuit lock compounds this problem by freezing the price at the floor, preventing sellers from exiting and potentially leading to multi-day circuit locks. This liquidity trap is a common challenge for small and micro-cap stocks hitting lower circuits. With unfilled supply and limited liquidity, how long can sellers remain trapped at these levels before the market finds a new equilibrium?

Brief Fundamental Context

Vivimed Labs Ltd operates within the Pharmaceuticals & Drugs industry, a sector often subject to regulatory and market volatility. While fundamentals are not the focus here, the micro-cap status and recent price action suggest that market sentiment is currently unfavourable. The stock’s recent performance, including a 2.92% decline on the day and underperformance relative to its sector by 4.57%, reflects this challenging environment.

Conclusion: Severity Assessment and Liquidity Caveats

The lower circuit lock at Rs 5.55 for Vivimed Labs Ltd is a clear indication of unfilled supply and persistent selling pressure. Rising delivery volumes confirm genuine liquidation by holders rather than speculative short-selling, while the stock’s position below all major moving averages underscores a sustained downtrend. The micro-cap liquidity profile intensifies exit risk, as sellers face difficulty finding buyers at these levels, potentially prolonging circuit locks. After a 4.97% single-day loss at lower circuit, is Vivimed Labs Ltd approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today